Clinic
Texas Health Harris Methodist Hospital Stephenville
Texas Health Harris Methodist Hospital Stephenville was paid $3.69M by Medicaid between Oct 2020 and Nov 2024, across 50 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoTEXAS HEALTH HARRIS METHODIST HOSPITAL STEPHENVILLE
STEPHENVILLE, TX 76401
STEPHENVILLE, TX 76401
33aNPI1922031541assigned 07/08/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.69M
24GClaims48,104
24DCodes billed50
24AFirst – last monthOct 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#97 of 320
Median peer was paid$205K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MINCHER, JEFF controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 648 | $56K | |
| 2021 | 12,284 | $788K | |
| 2022 | 17,054 | $1.31M | |
| 2023 | 13,179 | $1.13M | |
| 2024incomplete | 4,939 | $405K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 7,885 | 7,602 | $1.37M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 3,538 | 3,395 | $970K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.6% | 2,586 | 2,527 | $242K |
| 80053 | Comprehensive metabolic panel | 5.6% | 4,246 | 3,857 | $207K |
| 71045 | Radiologic examination, chest; single view | 3.4% | 1,713 | 1,589 | $124K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.2% | 5,883 | 5,304 | $119K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 2,463 | 2,400 | $103K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 892 | 861 | $101K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.7% | 661 | 591 | $98K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 2,427 | 2,374 | $90K |
| 81001 | 1.6% | 3,939 | 3,708 | $59K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 3,440 | 3,327 | $40K |
38 more codes
| 87634 | 1.0% | 310 | $37K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,134 | $35K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 158 | $22K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 517 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 138 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 604 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 328 | $5K |
| 84703 | <1% | 287 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 118 | $5K |
| 83690 | <1% | 319 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 29 | $4K |
| 84484 | <1% | 460 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 269 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 179 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 84 | $917.10 |
| CP007 | <1% | 14 | $654.24 | |
| 85018 | <1% | 13 | $328.50 | |
| 88720 | <1% | 25 | $273.34 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 279 | $252.70 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12 | $201.25 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $195.54 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 61 | $193.73 |
| 83655 | <1% | 13 | $189.16 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 28 | $150.12 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $146.30 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 37 | $121.68 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $73.48 |
| 83880 | <1% | 26 | $53.79 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $46.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 43 | $37.56 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $33.75 |
| 87040 | <1% | 73 | $28.28 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,071 | $10.89 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 127 | $9.30 |
| A9270 | Non-covered item or service | <1% | 1,476 | $2.41 |
| 83605 | 0% | 48 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 58 | $0.00 |
| 80164 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINCHER, JEFF (SENIOR VP REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Texas Health Harris Methodist Hospital Fort Worth | Fort Worth, TX | $13.83M |
| Texas Health Arlington Memorial Hospital | Arlington, TX | $8.23M |
| Texas Health Presbyterian Hospital Dallas | Dallas, TX | $5.33M |
| Texas Health Harris Methodist Hospital Southwest Fort Worth | Fort Worth, TX | $5.20M |
| Texas Health Presbyterian Hospital Kaufman | Kaufman, TX | $4.09M |
| Texas Health Presbyterian Hospital Denton | Denton, TX | $3.84M |
| Texas Health Harris Methodist Hospital Hurst-Euless-Bedford | Bedford, TX | $3.57M |
| Texas Health Presbyterian Hospital Plano | Plano, TX | $2.32M |
| Texas Health Harris Methodist Hospital Cleburne | Cleburne, TX | $2.31M |
| Texas Health Harris Methodist Hospital Azle | Azle, TX | $2.14M |
| Texas Health Harris Methodist Hospital Alliance | Fort Worth, TX | $986K |
| Texas Health Presbyterian Hospital Allen | Allen, TX | $965K |
| Texas Health Hospital Frisco | Frisco, TX | $473K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.